These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus. Zhang ZX; Zhao RP; Wang DS; Li YB Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086 [TBL] [Abstract][Full Text] [Related]
64. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models. Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997 [TBL] [Abstract][Full Text] [Related]
65. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease. Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887 [TBL] [Abstract][Full Text] [Related]
66. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer's disease. Ułamek-Kozioł M; Furmaga-Jabłońska W; Januszewski S; Brzozowska J; Sciślewska M; Jabłoński M; Pluta R Neurochem Res; 2013 Sep; 38(9):1769-73. PubMed ID: 23737325 [TBL] [Abstract][Full Text] [Related]
67. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease. Roy J; Tsui KC; Ng J; Fung ML; Lim LW Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125 [TBL] [Abstract][Full Text] [Related]
69. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease. Gallardo G; Holtzman DM Adv Exp Med Biol; 2019; 1184():187-203. PubMed ID: 32096039 [TBL] [Abstract][Full Text] [Related]
70. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496 [TBL] [Abstract][Full Text] [Related]
71. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders. Mold MJ; O'Farrell A; Morris B; Exley C J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074 [TBL] [Abstract][Full Text] [Related]
75. Recent advances of small molecule JNK3 inhibitors for Alzheimer's disease. Qin P; Ran Y; Liu Y; Wei C; Luan X; Niu H; Peng J; Sun J; Wu J Bioorg Chem; 2022 Nov; 128():106090. PubMed ID: 35964505 [TBL] [Abstract][Full Text] [Related]
76. Therapeutic treatment of Alzheimer's disease using metal complexing agents. Price KA; Crouch PJ; White AR Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229 [TBL] [Abstract][Full Text] [Related]
77. Progress in the development of new drugs in Alzheimer's disease. Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520 [TBL] [Abstract][Full Text] [Related]
78. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related]
79. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors. Takeda S Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962 [TBL] [Abstract][Full Text] [Related]
80. Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives. Zhang Z; Yang X; Song YQ; Tu J Ageing Res Rev; 2021 Dec; 72():101464. PubMed ID: 34551326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]